Home › Therapeutic areas › Neurology › Chronic Pain

Chronic Pain (3 companies)

Companies with an active program in Chronic Pain.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
AXSM Axsome Therapeutics Neurology Rare 1 Approved $6.96B 15
CTNM Contineum Therapeutics NeurologyRespiratory Rare 1 Phase 2 $374M 4
RAPP Rapport Therapeutics Neurology 1 Phase 3 $1.45B 10